{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T01:00:59Z","timestamp":1763686859315,"version":"3.45.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurophysiologie Clinique"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neucli.2025.103113","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:55:39Z","timestamp":1759992939000},"page":"103113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clarifying the diagnostic utility of decrement patterns in MuSK- and AChR-positive myasthenia gravis"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1004-2605","authenticated-orcid":false,"given":"Parth","family":"Aphale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5383-4226","authenticated-orcid":false,"given":"Himanshu","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7781-9987","authenticated-orcid":false,"given":"Shashank","family":"Dokania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neucli.2025.103113_bib0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp-2024-334584","article-title":"C5 complement inhibition and FcRn modulation in generalized myasthenia gravis","volume":"96","author":"McConville","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neucli.2025.103113_bib0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mus.26107","article-title":"Myasthenia gravis with muscle-specific tyrosine kinase antibodies: a narrative review","volume":"58","author":"Morren","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neucli.2025.103113_bib0003","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in MuSK myasthenia","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neucli.2025.103113_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.neucli.2025.103092","article-title":"Is the decrement pattern in myasthenia gravis due to muscle-specific kinase antibodies different to that due to acetylcholine receptor antibodies?","volume":"55","author":"Pegat","year":"2025","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.neucli.2025.103113_bib0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"}],"container-title":["Neurophysiologie Clinique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705325000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0987705325000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:42:40Z","timestamp":1763682160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0987705325000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0987705325000711"],"URL":"https:\/\/doi.org\/10.1016\/j.neucli.2025.103113","relation":{},"ISSN":["0987-7053"],"issn-type":[{"type":"print","value":"0987-7053"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clarifying the diagnostic utility of decrement patterns in MuSK- and AChR-positive myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neurophysiologie Clinique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neucli.2025.103113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103113"}}